As­traZeneca's can­cer com­bo wins sec­ond nod in one month, this time in lung can­cer

Weeks af­ter cel­e­brat­ing the first can­cer win for its Imfinzi and Imju­do duo, As­traZeneca is once again break­ing out the par­ty hats.

The mon­o­clon­al an­ti­body …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER